Reducing osteoarthritis pain

Osteoarthritis is classified as the most prevalent joint disorder, especially in middle-aged and elderly people, and is therefore seen as one of the ten most disabling diseases in developed countries.1

Current osteoarthritis management strategies focus on pain relief, function improvement, and quality of life maintenance. TRB Chemedica researches, develops, manufactures and markets different molecules to treat osteoarthritis-induced pain such as hyaluronic acid-based products and diacerein. OSTENIL® range consists of sodium hyaluronate-containing products with different formulations and has been developed to improve osteoarthritis patients’ symptoms and joint function after intra-articular injection.2-7 Due to its unique viscoelastic properties, hyaluronic acid has been used for many years as viscosupplement to treat osteoarthritis of the knee via intra-articular injection. Diacerein, which is obtained from Aloe Vera plants, is an active ingredient to treat osteoarthritis symptoms. Clinically, diacerein has demonstrated to efficiently relieve pain and improve joint function in patients with knee or hip osteoarthritis.

Tendinopaty at TRB Chemedica

Relieving painful tendinopathy

Tendinopathies are the most common tendon disorder mainly caused by overuse or inappropriate loading of tendons.10

OSTENIL® TENDON has been developed for the treatment of pain and restricted mobility in tendon disorders. Based on the biomechanical properties of hyaluronic acid, it has demonstrated to be efficacious and safe in treating rotator cuff/supraspinatus tendinopathy11,12, Achilles tendinopathy13,14, tennis elbow13 and peroneal tendinopathy13. Patients will benefit from rapid pain relief and a quick return to normal daily and sport activities. 11-14

Discover our treatments for tendinopathy and osteoarthritis

Learn more